Luciferase reporter gene assay on human 5-HT receptor: Which response element should be chosen?

Scientific Reports

Volumn 5, Issue , 2015, Pages 1-7

  Chen, Yiming ^a   Xu, Zhongyu ^a   Wu, Dang ^a   Li, Jian ^a   Song, Cheng ^b   Lu, Weiqiang ^a,c   Huang, Jin ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NANCHANG HANGKONG UNIVERSITY   (China)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; SEROTONIN RECEPTOR;

ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; DNA RESPONSIVE ELEMENT; GENETICS; HAMSTER; HUMAN; METABOLISM; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; GENES, REPORTER; HUMANS; LUCIFERASES; RECEPTORS, SEROTONIN; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 84923093515     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08060     Document Type: Article

References (18)

1. Thomsen, W., Frazer, J.&Unett, D. Functional assays for screening GPCR targets. Curr. Opin. Biotechnol. 16, 655-665 (2005).
2. Wise, A., Jupe, S. C. & Rees, S. The identification of ligands at orphang-protein coupled-receptors. Annu. Rev. Pharmacol. Toxicol. 44, 43-66 (2004).
3. Roeder, T., Görich, D., Heyden, D. & Geweckeb, M. A green-fluorescent -proteinbased assay for the characterization of G-protein-coupled receptors. Anal. Biochem. 332, 38-45 (2004).
4. Filip, M. & Bader, M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system. Pharmacol. Rep. 76, 761-777 (2009).
5. Hans, B. O. & Brann, M. R. Pharmacology of muscarinic acetylcholine receptor subtypes (ml-m5)" high throughput assays in mammalian cells. Eur. J. Pharmacol. 295, 93-102 (1996)
6. Cheng, Z. et al. Luciferase Reporter Assay System for Deciphering GPCR Pathways. Current Chemical Genomics. 4, 84-91 (2010).
7. Hill, S. J., Baker, J. G. & Rees, S. Reporter-gene systems for the study of G-proteincoupled receptors. Curr. Opin. Pharmacol. 1, 526-532 (2001).
8. Kvachnina, E. et al. 5-HT7 receptor is coupled to Ga subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. Ponimaskin. J. Neurosci. 25, 7821-7830 (2005).
9. Baker, L. P. et al. Stimulation of type 1 and type 8 Ca21/Calmodulin-sensitive adenylyl cyclases by Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J. Biol. Chem. 273, 17469-17476 (1998).
10. Raymond, J. R., Mukhin, Y. V., Gettys, T. W. & Garnovskaya, M. N. The recombinant 5-HT1A receptor: G protein coupling and signalling pathways. Br. J. Pharmacol. 127, 1751-1764 (1999).
11. Pauwels, P. J. & Colpaert, F. C. Ca21 responses in Chinese Hamster Ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation. J Pharmacol Exp Ther. 307, 608-614 (2003).
12. Williams, C. cAMP detection methods in HTS: selecting the best from the rest. Nat. Rev. Drug Discovery. 3, 125-135 (2004).
13. Raymond, J. R., Albers, F. J. &Middleton, J. P. Functional expression of human 5-HTIA receptors and differential coupling to second messengers in CHO cells. Naunyn Schmiedebergs Arch Pharmacol. 346, 127-137 (1992).
14. Philippe, S. & Daniel, H. Centrally acting hypotensive agents with affinity for 5-HTlA binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br. J. Pharmacol. 95, 975-985 (1988).
15. Wurch, T., Colpaert, F. C. & Pauwels, P. J. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca21 responses to partial as opposed to higher-efficacy 5-HT1A agonists. Neuropharmacology. 44, 873-881 (2003).
16. Porter, R. H. P. et al. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol. 128, 13-20 (1999).
17. Lestienne, L. R. et al . Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. Naunyn Schmiedebergs Arch Pharmacol. 376, 93-105 (2007).
18. Knight, J. A. et al. Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OHrisperidone, and other Inactivating Antagonists. Mol Pharmacol. 75, 374-380 (2009).